Market Overview

UPDATE: Benchmark Company Reiterates Buy Rating, Lowers PT on Analogic Corporation

Related ALOG
Top 4 NASDAQ Stocks In The Medical Laboratories & Research Industry With The Highest EPS
Mid-Day Gainers From December 10: Layne Christensen, Keurig Green Mountain, Burlington Stores And More

In a report published Wednesday, Benchmark Company reiterated its Buy rating on Analogic Corporation (NASDAQ: ALOG), but lowered its price target from $90.00 to $87.00.

Benchmark Company noted, “We are transitioning coverage of ALOG from the Defense & Homeland Security industry to the Medical Device industry. We believe that this transition better represents ALOG's business model, as 88% of ALOG's fiscal 2012 revenue was driven by their Medical Imaging and Ultrasound business while 12% of ALOG's revenue was driven by Security Technology.”

Analogic Corporation closed on Tuesday at $73.07.

Latest Ratings for ALOG

Sep 2014Brean CapitalDowngradesBuyHold
Jun 2014BenchmarkMaintainsBuy
Mar 2014CJS SecuritiesDowngradesMarket OutperformMarket Perform

View More Analyst Ratings for ALOG
View the Latest Analyst Ratings

Posted-In: Benchmark CompanyAnalyst Color Price Target Analyst Ratings


Related Articles (ALOG)

Around the Web, We're Loving...

Get Benzinga's Newsletters